Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE

Standard Dose
EQ 50MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 208741 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE Sponsor LUPIN Submission history Latest submission status date: 2023-08-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 208741 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE Sponsor LUPIN Submission history Latest submission status date: 2023-08-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.